The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Uhelak, Martin
    Director born in March 1985
    Individual (5 offsprings)
    Officer
    2016-04-07 ~ now
    OF - Director → CIF 0
    Mr Martin Uhelak
    Born in March 1985
    Individual (5 offsprings)
    Person with significant control
    2017-03-31 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 1
  • Uhelakova, Kristina
    Director born in March 1987
    Individual (5 offsprings)
    Officer
    2016-06-23 ~ 2017-03-31
    OF - Director → CIF 0
parent relation
Company in focus

ALMA PHARMA LTD

Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Turnover/Revenue
135,385 GBP2023-04-01 ~ 2024-03-31
167,963 GBP2022-04-01 ~ 2023-03-31
Raw materials and consumables used in the production process
-66,172 GBP2023-04-01 ~ 2024-03-31
-45,155 GBP2022-04-01 ~ 2023-03-31
Staff Costs/Employee Benefits Expense
-12,970 GBP2023-04-01 ~ 2024-03-31
-12,994 GBP2022-04-01 ~ 2023-03-31
Expenses related to depreciation, amortization, and impairment of assets
0 GBP2023-04-01 ~ 2024-03-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-8,495 GBP2023-04-01 ~ 2024-03-31
-19,780 GBP2022-04-01 ~ 2023-03-31
Profit/Loss
36,214 GBP2023-04-01 ~ 2024-03-31
322,827 GBP2022-04-01 ~ 2023-03-31
Called-up share capital not yet paid and not classified as a current asset
0 GBP2024-03-31
0 GBP2023-03-31
Fixed Assets
242,170 GBP2024-03-31
242,170 GBP2023-03-31
Current Assets
384,743 GBP2024-03-31
384,642 GBP2023-03-31
Creditors
Amounts falling due within one year
-226,110 GBP2024-03-31
-262,223 GBP2023-03-31
Net Current Assets/Liabilities
158,633 GBP2024-03-31
122,419 GBP2023-03-31
Total Assets Less Current Liabilities
400,803 GBP2024-03-31
364,589 GBP2023-03-31
Creditors
Amounts falling due after one year
0 GBP2024-03-31
0 GBP2023-03-31
Net Assets/Liabilities
400,803 GBP2024-03-31
364,589 GBP2023-03-31
Equity
400,803 GBP2024-03-31
364,589 GBP2023-03-31
Average Number of Employees
12023-04-01 ~ 2024-03-31

Related profiles found in government register
  • ALMA PHARMA LTD
    Info
    Registered number 10109625
    Pavilion Pharmacy, Brighton Terrace, London SW9 8DJ
    Private Limited Company incorporated on 2016-04-07 (9 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2024-04-01
    CIF 0
  • ALMA PHARMA LTD
    S
    Registered number missing
    Pavilion Pharmacy, Brighton Terrace, London, England, SW9 8DJ
    Private Limited Company
    CIF 1
  • ALMA PHARMA LTD
    S
    Registered number 10109625
    9, Brighton Terrace, Brixton, London, United Kingdom, SW9 8DJ
    Private Limited Company in Companies House, United Kingdom
    CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    PLEAT LIMITED - 2019-07-17
    POSTPAUSE LIMITED - 1990-05-09
    9 Brighton Terrace, Brixton, London, England
    Active Corporate (3 parents)
    Net Assets/Liabilities (Company account)
    151,438 GBP2023-03-31
    Person with significant control
    2022-08-02 ~ now
    CIF 1 - Ownership of shares – 75% or moreOE
    CIF 1 - Ownership of voting rights - 75% or moreOE
  • 2
    9 Brighton Terrace, Brixton, London, United Kingdom
    Active Corporate (3 parents)
    Person with significant control
    2025-01-15 ~ now
    CIF 2 - Ownership of shares – 75% or moreOE
    CIF 2 - Ownership of voting rights - 75% or moreOE
    CIF 2 - Right to appoint or remove directorsOE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.